gatc health corp irvinewhat smells deter cats from peeing

gatc health corp irvinepreschool graduation gowns uk

By licensing this new technology to GATC DB Care, we are allowing this platform to reach its full valuation potential in the US diabetes market, which accounted for $237 billion in direct medical costs in 2017, according to the American Diabetes Association. On May 12, 2021 the Company entered into a consultancy agreement with Dr. David Kushner. We may continue to enter into joint ventures for the exploitation of our technology. Maximum of 12,593,075 shares of Common Stock. No awards have been made under the Plan. If the trading price of our Common Stock declines significantly, you may be unable to resell your shares at or above the public offering price. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Predictive Multiomics enables individuals and their health care providers to not only become aware of the individuals predisposition to particular diseases, but the lifestyle changes which can reduce or potentially eliminate the onset of disease. Each item discussed above may delay, deter or prevent a change in control of our Company, even if a proposed transaction is at a premium over the then-current market price for our Common Stock. 818-610-0270. We plan to market test kits under our own name as well as under white label with the notation that the analysis is powered by GATC Health Corp. We may receive a flat fee, license fee and/or revenue-sharing basis, as negotiated. See Use of Proceeds.. The Company has entered into an agreement with FundAthena, Inc., d/b/a Manhattan Street Capital (Manhattan Street Capital) in connection with the use of its online platform for this offering. PRELIMINARY OFFERING CIRCULAR DATED JULY 12, 2021, INCLUDING UP TO 1,093,075 SHARES TO BE SOLD BY SELLING SHAREHOLDERS (1). The Company is engaged in the business of providing products and services for the gathering of human genome DNA, sequencing, and processing that sequence through artificial intelligence. Certain shareholders of the Company intend to sell up to 950,500 shares of Common Stock in this offering, not including shares that may be issued as perks. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANYS MANAGEMENT. These factors could adversely impact our growth and profitability in the future. DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES. We believe that DNA is the key to improved health. GATC Health Establishes East Coast Presence at WVU Innovation Corporation A diabetes Engine is being developed by an affiliated entity, GATC DB, and an unrelated entity is developing a cardiac health Engine. Risks of expansion of our business arise due to our limited operating history. Variations among organisms are due, in large part, to differences in their DNA sequences. As part of this investment, each investor will be required to agree to the terms of the Subscription Agreement included as Exhibit 4.1 to the Offering Statement of which this Offering Circular is part. GATC Health Corp. Dec 28, 2021, 14:00 ET. Large pharmaceutical companies are expanding into this field with increasing frequency. GATC Health is accelerating, optimizing and de-risking drug discovery and development like never before. GATC Health Corp. Irvine, CA. The period of time from inception until resolution of a patent dispute or litigation is subject to the availability and schedule of the court, agency or tribunal before which the dispute or litigation is pending. Additionally, early-stage companies are inherently more risky than more developed companies. This discussion contains forward-looking statements reflecting the Companys current expectations that involve risks and uncertainties. The Company is offering a up to 10 million shares (not including shares that may be issued as perks See Perks below) of our Common Stock at a price of $5.00 per share. Sequencing is the process of determining the nucleic acid sequence the order of nucleotides in DNA, RNA, or proteins. If the Company opposed a jury trial demand based on the waiver, a court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state and federal law. The lease rate per square foot of $4.00 is believed to be equivalent to the rate the Company would be required to pay to an unrelated party. IRVINE, Calif.-- ( BUSINESS WIRE )-- GATC Health, an innovative technology company focused on whole genome testing and Predictive Multiomics . The results are incorporated in our analytical algorithms. Risks related to our securities and the offering, There has been only no public market for our Common Stock and an active trading market for our Common Stock may not develop following this offering. COVID-19 has spread to many countries, including the United States, and was declared to be a pandemic by the World Health Organization. Our proposed products will face substantial competition. IRVINE, Calif., April 5, 2023 /PRNewswire/ -- GATC Health Corp, a technology company transforming drug discovery and disease prediction using proprietary, . You should read the following discussion and analysis of the consolidated financial statements and financial condition of GATC Health Corp. and results of its operations together with its financial statements and related notes appearing at the end of this Offering Circular. Related Persons. Either way, the holders of the convertible notes get more shares for their money than new investors. Future issuances of debt securities and equity securities may negatively affect the market price of shares of our Common Stock and, in the case of equity securities, may be dilutive to existing stockholders. GATC Health Establishes East Coast Presence at WVU Innovation Corporation The Company will make semi-annual filings on Form 1-SA, which will be due by September 28 each year, which will include unaudited financial statements for the six months to June 30. The Company may undertake one or more closings on a rolling basis. from 8 AM - 9 PM ET. Moreover, the COVID-19 outbreak has had and may continue to have indeterminable adverse effects on general commercial activity and the world economy, and the Companys business and results of operations could be adversely affected to the extent that COVID-19 or any other pandemic harms the global economy generally. Home - GATC Health The Act changes the current first-to-invent system to a system that awards a patent to the first-inventor-to-file for an application for a patentable invention. Certain aspects of MAT were developed by an unaffiliated company, Frlli Inc. and assigned to GATC Canna on July 7, 2019. In humans, genetic variation accounts for nearly all of the physical differences we see (e.g., height, hair, eye color, etc.). As payment for those consultancy services, the Company issued 160,000 shares of Common Stock to Ms. Scott for services rendered from September 2020 through December 2020. will be eligible to claim longer phase-in periods for the adoption of new or revised financial accounting standards. The shares of Common Stock were valued at $.50 per share. Provisions of Note in the Companys Subscription Agreement. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED BEFORE THE OFFERING STATEMENT FILED WITH THE COMMISSION IS QUALIFIED. WHEN USED IN THE OFFERING MATERIALS, THE WORDS ESTIMATE, PROJECT, BELIEVE, ANTICIPATE, INTEND, EXPECT AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD-LOOKING STATEMENTS. That amount is then shown as a percentage of the outstanding amount of securities in that class if no other people exercised their rights to acquire those securities. In May, 2021, the Company and Beyond Wellness and Fitness entered into a letter of intent for the development of an Engine relating to an individuals predisposition for heart attacks. reporting for self-diagnosis, health planning and longevity, Assistance to medical professionals in approaches for better patient outcomes, Identification of root cause and disease pathology, Prescreening clinical trial participants for predictive outcomes and anomalies, Assistance in creation of new drugs and therapeutic solutions, Repurposing existing drugs for alternate or off label applications. And Frlli, Inc, Assignment Agreement dated July 24, 2020 between Frlli, Inc (Assignor) GATC Canna and GATC Rx. Restrictions on Transfer: The Board of Directors may restrict the transfer of any of the Corporations Common Stock or any other securities which the Corporation may now or hereafter authorize to issue by giving the Corporation or any stockholder first right of refusal to purchase the stock, by making the stock redeemable or by restricting the transfer of the stock under such terms and in such manner as the directors may deem necessary and as are not inconsistent with the laws of the State of Wyoming. From August 2002 to May 2005, he was Lead Application Architect and a consultant to American Express. These changes may result in certain genes becoming overexpressed (excessive protein production), under-expressed (reduced protein production), or silenced altogether, sometimes triggering changes in cellular function. Internet Explorer presents a security risk. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. "I'm thrilled GATC Health has chosen West Virginia University to establish an innovative artificial intelligence-driven research and development hub to advance our understanding of drug development and substance use disorder. We are sorry, but your computer or network may be sending automated queries. We do not know what the terms of any future capital raising may be but any future sale of our equity securities will dilute the ownership of existing stockholders and could be at prices substantially below the price of the shares of Common Stock sold in this offering. The Subscription Agreement includes a representation by the investor to the effect that, if you are not an accredited investor as defined under securities law, you are investing an amount that does not exceed the greater of 10% of your annual income or 10% of your net worth (excluding your principal residence). GATC recently completed a study demonstrating that its MAT platform can successfully predict the positive human outcome of a compound with 88% accuracy and forecast drug failure with an unprecedented 84% accuracy rate an 11x increase over the current industry lead optimization success rates. Our proposed products may become subject to regulatory approval. Any convertible preferred units would have, and any series or class of our preferred stock would likely have, a preference on distribution payments, periodically or upon liquidation, which could eliminate or otherwise limit our ability to make distributions to Common Stockholders. In other words, when the Company issues more shares, the percentage of the Company that you own will go down, even though the value of the Company may go up. Note that this offering, while a public offering, is not a sale of common equity pursuant to a registration statement, since the offering is conducted pursuant to an exemption from the registration requirements. Mr. Jenkins also served in key marketing and product development roles at Systemic Formulas, Inc. and Orn Industries. If the Company successfully raises $20,430,000 in net proceeds, it intends to use the proceeds as follows: (a) research and development, including expansion of our technical team and developing new disease platforms for $9.5 million and general research and development staff of $2.3 million; (b) hiring of a grant team to obtain government grants for genetic research projects, $400,000; (c) marketing costs and public relations of $8.4 million; (d) cyber security costs of $630,000; (e) strategic acquisitions of other companies in related businesses of $5.2 million, and (f) the remainder of $4,060,000 for general and administrative expenses, including $300,000 in accrued compensation to consultants of which $51,000 is owed to officers of the Company. We plan to continue to seek additional patent protection relating to our technology and future products. After each closing, funds tendered by investors will be available to the Company. As of May 2021, we have licensed MAT to the following entities: On March 23, 2021 the Company and GATC DB Care Corp., (GATC DB) entered into a licensing agreement related to Type I and Type II diabetes. Sakura Tran beneficially owns these shares through Evolutionary Analytics, LLC a limited liability company of which she is the sole member. During the period from Inception to December 31, 2020, net cash flows used in operating activities was $857,176, financing activities provided $1,186,250 in cash, and investing activities, consisting of capitalized software development costs, used $268,200 in cash. The Company capitalized $268,000 in software development costs incurred during this period. with up to 5 times the number of maximum matches per search vs. non-subscribers. In addition, patent. securities and other loans and preferred stock will receive a distribution of our available assets before Common Stockholders. Through GATC Canna, which is has some shareholders in common with us, we have developed an Engine to assist medical professionals in prescribing the appropriate cannabis-based medications. Together we are going to establish new best-practices of leveraging advanced AI to discover better drugs faster.". We may not be able to develop commercial products. Buzzfile's Basic (Free) service is available to users for light non-commercial use only. Our rights and the rights of our stockholders to take action against our directors and officers are limited, which could limit your recourse in the event of actions that you do not believe are in your best interests. The Company, however, may find it necessary or advisable to re-allocate portions of the net proceeds reserved for one category to another, and it will have broad discretion in doing so. Accordingly, in the event that actions taken in good faith by any of our directors or officers impede the performance of our Company, your ability to recover damages from such director or officer will be limited. Using a credit card is a relatively new form of payment for securities and will subject you to other risks inherent in this form of payment, including that, if you fail to make credit card payments (e.g. The merger is subject to approval by the majority of the minority shareholders, at a special meeting scheduled for July 15, 2021. There can be no assurance that such additional capital will be available to us on favorable terms or at all. Although the genetic data we obtain is de-identified, we consider cyber security to be of the utmost importance, and plan to obtain, either via contract or through internal staff, the highest level of cyber security we can, given financial and technological constraints. Cash management fee of 0.5% of funds processed (up to a maximum of $8,000). Following the completion of this Offering, the Board of Directors intends to develop a structure to re-evaluate compensation levels, after seeking input from one or more outside compensation consultants. , . Certain investors are entitled to pay a lower price for the companys Common Stock. GATC Cannas Engine is marketed to assist medical professionals in diagnosing specific cannabis products such as CBD to optimize health and wellness. For details of the effective discount, see Plan of Distribution and Selling Shareholders - Perks.. We plan to launch one new Engine development project every two months, with each project requiring, on an average, 90 days to develop. "The WVUIC facility is ideal for our vision and will help bring these important treatments to people sooner. "We will be hiring life sciences and biotech focused teams, R&D lab technicians and administrative staff to further attract partnering businesses to this facility and delivering back significant advances in treatments that greatly affect the 13 states across the Appalachian region.". The total number of shares owned by the selling shareholders prior to this offering represents 21.3% of the Companys capital stock, on a fully diluted basis, assuming all options are exercised and all shares of Preferred Stock are converted to Common Stock. FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2020. The Company subleases approximately 2,500 square feet of office space on a month to month basis from ONIT. Our failure to obtain capital may significantly restrict our proposed operations. We will likely outsource our customer service requirements for tracking the testing process and providing reports on a timely basis to an outside company, so that we may focus our efforts on our core business activities. The Company has 8 full-time employees and no part-time employees. Company Lists & Search Criteria, Advanced Search (filter by dozens of criteria including revenue, employees, business activity, geography, distance, industry, age, phone & demographics), Building & Tenant Search by Address or Street Name, Create, Save & Share Place Lists and Search Criteria, Access Information on 40+ million Contacts ( No Email), Create, Save & Share Contact Lists & Search Criteria, Contact Information Export Limits (No Email Addresses), Monthly Subscription - Contact Email Address Limits, Annual Subscription - Contact Email Address Limits. Third parties may challenge, invalidate or circumvent our patents and patent applications relating to our products, product candidates and technologies. GATC's Multiomics Advanced Technology (MAT) platform simulates biochemical interactions to accurately predict the body's response of a pharmaceutical asset to a specific disease. The impacts of the outbreak are unknown and rapidly evolving. The shares of Common Stock were valued at $.50 per share. By resolution of the board of directors, (the Board of Directors) dated March 31, 2021, the Company agreed to issue 2,431,000 shares of Common Stock to acquire the minority interests in GATC Rx, via merger with a subsidiary to be organized for this purpose. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. The total retail price for the test kit and analysis varies, but is generally from $400 to $500 per individual. He is a licensed California real estate broker and as such is licensed to receive commissions on business acquisitions. Technical and scientific staff currently work remotely. Dr. Lakey has served as a member of the Board of Advisors since February 2021 Dr. Lakey has had a long interest and research direction in cell and tissue transplantation with a focus on diabetes and islet transplantation. He was lead developer and architect for PerfectPracticeMD (now Advanced MD) which was then acquired by ADP. However, the Company believes that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of Wyoming, which governs the Agreement, by a federal or state court in the State of Wyoming. Filing Jurisdiction, Entity Type, Registered Agent, File Number, Filing Status, and Business Category. He was Chief Science Officer and Senior Vice President of Yulex Corporation, which was engaged in applying modern genomic tools to improve crop productivity and producing high performance hybrid Guayule parthenium planting materials for the production of sustainable biomaterials including allergy-free latex products, bio rubber, biomass and resin-based specialty chemicals, from April 2014 to January 2017. Marketing, Sales and Customer Fulfillment. Dependence on Key Personnel. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. For more than the past five years he has been a practicing radiologist in Iowa City, Iowa and received his medical degree from Case Western University. On April 1, 2020, the Company entered into a consulting agreement with Gerry Martin. Deficiencies, including any material weakness, in our internal control over financial reporting which may occur in the future could result in misstatements of our results of operations, restatements of our financial statements, a decline in our stock price, or otherwise materially adversely affect our business, reputation, results of operations, financial condition or liquidity. Establish GATC Healths standing in the genomics community as one of the businesses in the forefront of the industry. Drawing on massive sets of public and proprietary data, our AI simulates human biologys billions of interactions simultaneously for rapid and accurate target discovery, drug identification, development and validation. MAT is not limited to analysis of the human genome. GATC Health Corp. (the Company) is engaged in the business of providing products and services for the gathering of human genome DNA, sequencing, and processing that sequence through artificial intelligence. This Offering Statement has been signed by the following person in the capacities indicated on July 12, 2021. Assuming a maximum raise of $50,000,000, (and assuming no shares are issued as perks, see Plan of Distribution and Selling Shareholders - Perks), the net proceeds of this offering would be approximately $46,180,000 after subtracting sales by selling shareholders, estimated offering costs of $120,000 in advisory fees payable to Manhattan Street Capital, as well as 7% in transaction fees as set forth under the caption Plan of Distribution and Selling Shareholders above of $3,500,000, and $200,000 in legal, accounting and other fixed costs of the offering. We currently rely on Gene by Gene, Ltd., (Gene by Gene) as our supplier of test kits and initial DNA sequencing. These nucleotide bases occur in a precise order known as the DNA sequence. Providing expert guidance to GATCs management is the companys stellar Board of Advisors, which includes top researchers, medical doctors, employee benefits experts, biotech executives and government contracting experts. The Companys Consolidated Financial Statements include a Going Concern Opinion. These tests are ordered by medical practitioners and cost about $300 to $500; most if not all are covered by insurance. West Virginia and the surrounding Appalachian region have one of the highest incidences of PTSD per capita in the nation. The Company was incorporated on May 16, 2020, and commenced operations shortly thereafter. To protect our site, we cannot process your request right now. Chairman and Director (Principal Executive Officer), Chief Financial Officer and Director (Principal Accounting and Financial Officer). GATC Health Corp 3 years 5 months President Apr 2020 - Present3 years 3 months Irvine, California, United States GATC Health is a pioneering technology company and the first to develop. In addition, our Articles of Incorporation will authorize us to obligate us, and our bylaws will require us, to indemnify our directors for actions taken by them in those capacities to the maximum extent permitted by Wyoming law. GATC HEALTH CORP: Street Address 1 Street Address 2; 2030 MAIN STREET: SUITE 660: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; IRVINE: CALIFORNIA: 92614: 9492608070: 3. All shareholders were given the opportunity to convert their common shares into Series A Convertible Preferred Stock. If you are making an investment expecting to own a certain percentage of the Company or expecting each share to hold a certain amount of value, its important to realize how the value of those shares can decrease by actions taken by the Company. Our advanced technology platform closes the AI Gap to save years of R&D time and potentially hundreds of millions of dollars per project for our pharma partners. The following table presents the approximate effective cash price paid for all shares and potential shares issuable by the Company as of December 31, 2020 after giving effect to the Stock Split and the conversion of the Debentures and interest thereon. The Company subleases approximately 2,500 square feet of office space on a month to month basis in a modern office building from ONIT Sciences, Inc., a company under common control with the Company, and also reimburses ONIT for health insurance premiums of approximately $4,500 per month paid by ONIT on behalf of certain Company consultants as part of their agreements. The Company has also engaged Colonial Stock Transfer (the Transfer Agent), a registered transfer agent with the Securities and Exchange Commission, who will serve as Transfer Agent to maintain stockholder information on a book-entry basis. About GATC Health is a technology company that develops predictive multi-omics advanced technology. Raised funds to launch our business model. The additional classes or series will be available for issuance without further action by our stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded.

Lamb And Webster Inventory, Sugar Scrub Business Names, Skechers Dual Lite Slip On, Kopi Luwak Coffee How Is It Made, Articles G